TNSN97045A1 - Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn, vecteur, organismes hote, tests et vaccins correspondants, et leur utilisation. - Google Patents
Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn, vecteur, organismes hote, tests et vaccins correspondants, et leur utilisation.Info
- Publication number
- TNSN97045A1 TNSN97045A1 TNTNSN97045A TNSN97045A TNSN97045A1 TN SN97045 A1 TNSN97045 A1 TN SN97045A1 TN TNSN97045 A TNTNSN97045 A TN TNSN97045A TN SN97045 A TNSN97045 A TN SN97045A TN SN97045 A1 TNSN97045 A1 TN SN97045A1
- Authority
- TN
- Tunisia
- Prior art keywords
- genes
- histones
- trypanosomatides
- vaccines
- derivatives
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 8
- 108010033040 Histones Proteins 0.000 title abstract 6
- 102000006947 Histones Human genes 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000010276 construction Methods 0.000 title 1
- 238000012360 testing method Methods 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
L'INVENTION CONCERNE DES HISTONES DE TRYPANOSOMATIDES SOUS FORME SENSIBLEMENT ISOLEES DESTINEES A ETRE UTILISEES COMME ANTIGENES PROTECTEURS CONTRE LES INFECTIONS A TRYPANOSOMATIDES, LESQUELLES HISTONES PEUVENT ETRE ISOLEES A PARTIR DU PARASITE CORRESPONDANT OU PRODUITES PAR DES TECHNIQUES D'ADN RECOMBINE, AUQUEL CAS L'INVENTION CONCERNE EGALEMENT DES GENES CODANT DES HISTONES, NOTAMMENT DES GENES QUI S'HYDRIDENT A UNE PARTIE AU MOINS DE LA SEQUENCE NUCLEOTIDIQUE REPRESENTEE SUR LA FIGURE 6A, ET DES DERIVES DES GENES TELS QUE D'AUTRES ACIDES NUCLEIQUES ET DES PRODUITS GENIQUES TES QUE DES PEPTIDES ET DES PROTEINES, ET EGALEMENT DES TESTS DE DIAGNOSTIC, DES COMPOSITIONS PHARMACEUTIQUES ET DES VACCINS COMPRENANT LES EXCIPIENTS ET/OU ADJUVANTS USUELS ET AU MOINS UNE HISTONE, UN GENE CODANT UNE HISTONE OU UN DERIVE DE CELUI-CI.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96200665 | 1996-03-12 | ||
| EP96201343 | 1996-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN97045A1 true TNSN97045A1 (fr) | 2005-03-15 |
Family
ID=26142593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN97045A TNSN97045A1 (fr) | 1996-03-12 | 1997-03-11 | Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn, vecteur, organismes hote, tests et vaccins correspondants, et leur utilisation. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0896623A1 (fr) |
| JP (1) | JP2000507098A (fr) |
| CN (1) | CN1216584A (fr) |
| AU (1) | AU733720B2 (fr) |
| BR (1) | BR9708188A (fr) |
| CA (1) | CA2248684A1 (fr) |
| IL (1) | IL126145A0 (fr) |
| MA (1) | MA25182A1 (fr) |
| NZ (1) | NZ331889A (fr) |
| TN (1) | TNSN97045A1 (fr) |
| TR (1) | TR199801776T2 (fr) |
| WO (1) | WO1997033999A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1687023B1 (fr) * | 2003-11-05 | 2012-10-03 | C.B.F. Leti, S.L. Unipersonal | Application d'histones specifiques au traitement de maladies parasitaires |
| FR2952382B1 (fr) * | 2009-11-10 | 2011-11-25 | Univ Victor Segalen Bordeaux 2 | Vaccins et diagnostics contre les trypanosomoses animales africaines |
| BRPI1003744B1 (pt) * | 2010-06-08 | 2021-10-26 | Universidade Federal De Ouro Preto | E-ntpdases recombinantes, uso na produção de kit de diagnóstico para detecção de anticorpos nas leishmanioses causadas por espécies do gênero leishmania |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8722741D0 (en) * | 1987-09-28 | 1987-11-04 | Hoffmann La Roche | Induction of cytotoxic t cell response |
-
1997
- 1997-03-11 TN TNTNSN97045A patent/TNSN97045A1/fr unknown
- 1997-03-11 MA MA24516A patent/MA25182A1/fr unknown
- 1997-03-12 CA CA002248684A patent/CA2248684A1/fr not_active Abandoned
- 1997-03-12 CN CN97193835A patent/CN1216584A/zh active Pending
- 1997-03-12 EP EP97908233A patent/EP0896623A1/fr not_active Withdrawn
- 1997-03-12 AU AU20272/97A patent/AU733720B2/en not_active Ceased
- 1997-03-12 NZ NZ331889A patent/NZ331889A/xx unknown
- 1997-03-12 JP JP9532298A patent/JP2000507098A/ja not_active Withdrawn
- 1997-03-12 TR TR1998/01776T patent/TR199801776T2/xx unknown
- 1997-03-12 BR BR9708188-4A patent/BR9708188A/pt not_active IP Right Cessation
- 1997-03-12 WO PCT/EP1997/001289 patent/WO1997033999A1/fr not_active Application Discontinuation
- 1997-03-12 IL IL12614597A patent/IL126145A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR199801776T2 (xx) | 1998-12-21 |
| JP2000507098A (ja) | 2000-06-13 |
| IL126145A0 (en) | 1999-05-09 |
| AU2027297A (en) | 1997-10-01 |
| CA2248684A1 (fr) | 1997-09-18 |
| BR9708188A (pt) | 2000-01-18 |
| CN1216584A (zh) | 1999-05-12 |
| AU733720B2 (en) | 2001-05-24 |
| NZ331889A (en) | 2000-12-22 |
| WO1997033999A1 (fr) | 1997-09-18 |
| EP0896623A1 (fr) | 1999-02-17 |
| MA25182A1 (fr) | 2001-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004528266A (ja) | 薬物送達用組成物 | |
| DE69732029D1 (de) | Dna enthaltende impfstoffen | |
| Lucchesi et al. | A DNA fragment of Leptospira interrogans encodes a protein which shares epitopes with equine cornea | |
| TNSN97045A1 (fr) | Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn, vecteur, organismes hote, tests et vaccins correspondants, et leur utilisation. | |
| FR2744455B1 (fr) | Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications | |
| AU2002211446A1 (en) | 32144, a human fatty acid amide hydrolase and uses thereof | |
| CA2204511A1 (fr) | Production de peptides recombinants, analogues de peptides naturels hydrophobes | |
| WO2002008273A3 (fr) | 47508, un nouveau membre de la famille de l'histone deacetylase humaine et utilisations associees | |
| WO2001092493A3 (fr) | Nouvelles aminopeptidases humaines 21956 et 25856, et utilisations | |
| DE60142356D1 (de) | 18480 humane proteinkinasemoleküle und ihre verwendungen | |
| WO2001075121A3 (fr) | 16836, un nouvel element de la famille de la phospholipase c humaine et ses utilisations | |
| WO2001064904A3 (fr) | Membres de la famille transferase 25324, 50287, 28899, 47007, et 42967 et utilisations de ces derniers | |
| WO2001066765A3 (fr) | 26583, nouvelle serine/threonine phosphatase et utilisations correspondantes | |
| FR2726577A1 (fr) | Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament | |
| WO2001079473A3 (fr) | Nouveau membre de la famille de la prolyl oligopeptidase humaine, appele 21953, et ses utilisations | |
| WO2003020912A3 (fr) | Nouvelle proteine cark et molecules d'acides nucleiques et leurs utilisation | |
| WO2001066764A3 (fr) | 16835, un nouvel element de la famille c de phospholipase humaine et utilisations correspondantes | |
| WO2002006485A3 (fr) | 47885, une nouvelle enzyme activant l'ubiquitine humaine et ses applications | |
| WO2002020801A3 (fr) | 26199, 33530, 33949, 47148, 50226, et 58764, nouveaux membres de la famille des transferases humaines et utilisations de ceux-ci | |
| Trueba et al. | Cloning of the pfaP gene of Leptospira borgpetersenii | |
| Downard | STUDIES ON THE SYNTHESIS OF SPECIFIC RNAS DURING INFECTION OF BACILLUS SUBTILIS BY BACTERIOPHAGE SP01. | |
| WO2002088357A3 (fr) | Nouvelles proteines humaines 84242, 8035, 55304, 52999 et 21999 et procedes de production desdites proteines | |
| WO2002002761A3 (fr) | 57658, nouvelle uridine kinase humaine et utilisations correspondantes | |
| AU2001288284A1 (en) | 14189, a human kinase and uses thereof | |
| WO2002006326A3 (fr) | 62088, un nouveau membre humain de la famille nucleoside phosphatase, et utilisations de ce dernier |